Constraints on the experimental design process in real-world science

被引:0
|
作者
Baker, LM [1 ]
Dunbar, K [1 ]
机构
[1] MCGILL UNIV,DEPT PSYCHOL,MONTREAL,PQ H3A 1B1,CANADA
关键词
D O I
暂无
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
引用
收藏
页码:154 / 159
页数:6
相关论文
共 50 条
  • [41] DESIGN REAL-WORLD STRIPLINE CIRCUITS.
    Gupta, K.C.
    Chadha, Rakesh
    1978, 17 (12): : 70 - 71
  • [42] Key considerations in the design of real-world studies
    Fang, Yixin
    He, Weili
    Wang, Hongwei
    Wu, Meijing
    CONTEMPORARY CLINICAL TRIALS, 2020, 96
  • [43] Design and Visualization for Exploring Real-World Data
    Zhang, Richard
    IEEE COMPUTER GRAPHICS AND APPLICATIONS, 2021, 41 (02) : 23 - 23
  • [44] The Real-World Dilemma of Security and Privacy by Design
    Sadeghisecurity, Ahmad-Reza
    COMMUNICATIONS OF THE ACM, 2021, 64 (10) : 84 - 84
  • [45] FORMAL VERIFICATION - IS IT PRACTICAL FOR REAL-WORLD DESIGN
    CAMURATI, P
    CHIN, SK
    FOURMAN, M
    PRINETTO, P
    TAKAHARA, A
    IEEE DESIGN & TEST OF COMPUTERS, 1989, 6 (06): : 50 - 58
  • [46] Reflections of the real-world in the unreal, using simulation to design complex real-world validation studies for spectroscopy
    Beattie, J. Renwick
    JOURNAL OF RAMAN SPECTROSCOPY, 2021, : 2683 - 2698
  • [47] Reflections of the real-world in the unreal, using simulation to design complex real-world validation studies for spectroscopy
    Beattie, J. Renwick
    Beattie, J. Renwick (rene@jrenwickbeattie.com), 1600, John Wiley and Sons Ltd (52): : 2683 - 2698
  • [48] Real-world trials to answer real-world questions
    Freemantle, N
    Blonde, L
    Bolinder, B
    Gerber, RA
    Hobbs, FDR
    Martinez, L
    Ross, S
    PHARMACOECONOMICS, 2005, 23 (08) : 747 - 754
  • [49] Translating real-world evidence/real-world data
    Ravenstijn, Paulien
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):
  • [50] Real-world trials to answer real-world questions
    Nick Freemantle
    Lawrence Blonde
    Bjorn Bolinder
    Robert A. Gerber
    F. D. Richard Hobbs
    Luc Martinez
    Stuart Ross
    PharmacoEconomics, 2005, 23 : 747 - 754